INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 201 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 1.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $185,000 | -6.6% | 8,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $198,000 | -99.3% | 8,000 | -98.9% | 0.00% | -99.5% |
| Q3 2020 | $29,229,000 | -13.5% | 704,976 | 0.0% | 0.40% | -15.5% |
| Q2 2020 | $33,775,000 | -24.3% | 704,976 | -0.6% | 0.48% | -44.8% |
| Q1 2020 | $44,638,000 | -49.6% | 708,976 | -0.9% | 0.87% | -38.4% |
| Q4 2019 | $88,624,000 | +90.2% | 715,176 | +1.9% | 1.40% | +62.1% |
| Q3 2019 | $46,596,000 | -17.7% | 702,176 | -1.4% | 0.87% | -10.3% |
| Q2 2019 | $56,638,000 | +2839.2% | 711,803 | +4031.9% | 0.97% | +812.3% |
| Q1 2019 | $1,927,000 | -17.4% | 17,227 | -25.6% | 0.11% | -30.7% |
| Q4 2018 | $2,333,000 | -23.5% | 23,148 | -4.1% | 0.15% | -21.1% |
| Q3 2018 | $3,051,000 | +47.5% | 24,148 | -2.0% | 0.19% | +10.2% |
| Q2 2018 | $2,068,000 | +5.4% | 24,648 | -22.7% | 0.18% | -9.3% |
| Q1 2018 | $1,962,000 | +73.2% | 31,900 | +64.4% | 0.19% | +64.4% |
| Q4 2017 | $1,133,000 | +129.8% | 19,400 | +128.2% | 0.12% | +126.9% |
| Q3 2017 | $493,000 | -52.1% | 8,500 | 0.0% | 0.05% | -57.4% |
| Q2 2017 | $1,029,000 | +7.1% | 8,500 | 0.0% | 0.12% | -4.7% |
| Q1 2017 | $961,000 | +4.0% | 8,500 | 0.0% | 0.13% | -32.3% |
| Q4 2016 | $924,000 | -58.4% | 8,500 | -37.0% | 0.19% | -52.9% |
| Q3 2016 | $2,222,000 | +15.4% | 13,500 | 0.0% | 0.40% | +10.8% |
| Q2 2016 | $1,926,000 | +11.1% | 13,500 | 0.0% | 0.36% | +14.9% |
| Q1 2016 | $1,734,000 | – | 13,500 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
| Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
| Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
| Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
| Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
| BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
| DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
| Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
| Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |